Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
CHRISTUS Santa Rosa Children's Hospital
mi
from
San Antonio, TX
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
CHRISTUS Santa Rosa Children's Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Methodist Healthcare System of San Antonio
mi
from
San Antonio, TX
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Methodist Healthcare System of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Scott & White Pediatrics
mi
from
Temple, TX
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Scott & White Pediatrics
mi
from
Temple, TX
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Hospital for Sick Children
mi
from
Toronto,
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Children's National Medical Center
mi
from
Washington, D.C.,
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Children's National Medical Center
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Palms West Hospital
mi
from
Loxahatchee Groves, FL
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Palms West Hospital
mi
from
Loxahatchee Groves, FL
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Columbia University Medical Center
mi
from
New York, NY
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase I/II Trial of Temsirolimus and Perifosine for Recurrent or Progressive Malignant Gliomas
Status: Enrolling
Updated:  10/31/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase I/II Trial of Temsirolimus and Perifosine for Recurrent or Progressive Malignant Gliomas
Status: Enrolling
Updated: 10/31/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase I/II Trial of Temsirolimus and Perifosine for Recurrent or Progressive Malignant Gliomas
Status: Enrolling
Updated:  10/31/2017
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase I/II Trial of Temsirolimus and Perifosine for Recurrent or Progressive Malignant Gliomas
Status: Enrolling
Updated: 10/31/2017
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase I/II Trial of Temsirolimus and Perifosine for Recurrent or Progressive Malignant Gliomas
Status: Enrolling
Updated:  10/31/2017
Memorial Sloan Kettering at Basking Ridge
mi
from
Basking Ridge, NJ
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase I/II Trial of Temsirolimus and Perifosine for Recurrent or Progressive Malignant Gliomas
Status: Enrolling
Updated: 10/31/2017
Memorial Sloan Kettering at Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated:  10/31/2017
Stanford University School of Medicine
mi
from
Stanford, CA
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated: 10/31/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated:  10/31/2017
Markey Cancer Center, Clinical Research Office
mi
from
Lexington, KY
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated: 10/31/2017
Markey Cancer Center, Clinical Research Office
mi
from
Lexington, KY
Click here to add this to my saved trials
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated:  10/31/2017
Duke Univ Med Ctr
mi
from
Durham, NC
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated: 10/31/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated:  10/31/2017
Froedtert Hospital, Medicial College of Wisconsin
mi
from
Milwaukee, WI
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated: 10/31/2017
Froedtert Hospital, Medicial College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated:  10/31/2017
Montefiore
mi
from
Bronx, NY
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated: 10/31/2017
Montefiore
mi
from
Bronx, NY
Click here to add this to my saved trials
A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation
A Pilot Study of Tumor Lysate-pulsed Dendritic Cell Vaccine for Immune Augmentation for High-risk Solid Tumor Patients Following Autologous Stem Cell Transplantation
Status: Enrolling
Updated:  11/2/2017
University of Michigan, Department of Surgery, Pediatric Section
mi
from
Ann Arbor, MI
A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation
A Pilot Study of Tumor Lysate-pulsed Dendritic Cell Vaccine for Immune Augmentation for High-risk Solid Tumor Patients Following Autologous Stem Cell Transplantation
Status: Enrolling
Updated: 11/2/2017
University of Michigan, Department of Surgery, Pediatric Section
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Arizona Oncology Services Foundation
mi
from
Phoenix, AZ
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Arizona Oncology Services Foundation
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
University of Florida Shands Cancer Center
mi
from
Gainesville, FL
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
University of Florida Shands Cancer Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Integrated Community Oncology Network
mi
from
Jacksonville Beach, FL
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Integrated Community Oncology Network
mi
from
Jacksonville Beach, FL
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Baptist Cancer Institute - Jacksonville
mi
from
Jacksonville, FL
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Baptist Cancer Institute - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Integrated Community Oncology Network at Southside Cancer Center
mi
from
Jacksonville, FL
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Integrated Community Oncology Network at Southside Cancer Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Integrated Community Oncology Network - Orange Park
mi
from
Orange Park, FL
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Integrated Community Oncology Network - Orange Park
mi
from
Orange Park, FL
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Florida Cancer Center - Palatka
mi
from
Palatka, FL
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Florida Cancer Center - Palatka
mi
from
Palatka, FL
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Flagler Cancer Center
mi
from
Saint Augustine, FL
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Flagler Cancer Center
mi
from
Saint Augustine, FL
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
DeCesaris Cancer Institute at Anne Arundel Medical Center
mi
from
Annapolis, MD
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
DeCesaris Cancer Institute at Anne Arundel Medical Center
mi
from
Annapolis, MD
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Greenebaum Cancer Center at University of Maryland Medical Center
mi
from
Baltimore, MD
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Greenebaum Cancer Center at University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Josephine Ford Cancer Center at Henry Ford Hospital
mi
from
Detroit, MI
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Josephine Ford Cancer Center at Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Sparrow Regional Cancer Center
mi
from
Lansing, MI
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Sparrow Regional Cancer Center
mi
from
Lansing, MI
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
CCOP - Kansas City
mi
from
Kansas City, MO
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
CCOP - Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Methodist Estabrook Cancer Center
mi
from
Omaha, NE
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Methodist Estabrook Cancer Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
mi
from
Lebanon, NH
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Mission Hospitals - Memorial Campus
mi
from
Asheville, NC
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Mission Hospitals - Memorial Campus
mi
from
Asheville, NC
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Jean and Milton Cooper Cancer Center at Summa Akron City Hospital
mi
from
Akron, OH
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Jean and Milton Cooper Cancer Center at Summa Akron City Hospital
mi
from
Akron, OH
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Aultman Cancer Center at Aultman Hospital
mi
from
Canton, OH
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Aultman Cancer Center at Aultman Hospital
mi
from
Canton, OH
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
The Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
The Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford
mi
from
Salem, OH
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford
mi
from
Salem, OH
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Cancer Treatment Center
mi
from
Wooster, OH
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Cancer Treatment Center
mi
from
Wooster, OH
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Rosenfeld Cancer Center at Abington Memorial Hospital
mi
from
Abington, PA
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Rosenfeld Cancer Center at Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated:  11/6/2017
Penn State Cancer Institute at Milton S. Hershey Medical Center
mi
from
Hershey, PA
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
Status: Enrolling
Updated: 11/6/2017
Penn State Cancer Institute at Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials